Valeant rumored to be interested in Zoetis

The Wall Street Journal reported that Valeant Pharmaceuticals International Inc. (NYSE: VRX) was exploring a possible acquisition of Zoetis Inc. (NYSE: ZTS). Shares of Valeant Pharmaceuticals plunged $4.38 to close at $228.83 while Zoetis stock plummeted $6.76 to close at $48.62.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.